Lixte Biotechnology Holdings Says Combination Therapy Kills Cancer Cells in Animals; Shares Soar

MT Newswires 2023

All news about LIXTE BIOTECHNOLOGY HOLDINGS, INC.

01:27p	Lixte Biotechnology Holdings Says Combination Therapy Kills Cancer Cells in Animals; Sh..	MT
12:17p	Lixte biotechnology holdings, inc. reports that its lead clinical compound, lb-100, can..	AQ
01/23	Lixte Biotechnology : Investor Fact Sheet – January 2023	PU
2022	Lixte Biotechnology : Other Items – Form 8-K	PU
2022	Lixte Biotechnology Holdings, Inc. : Other Events (form 8-K)	AQ
2022	Stocks Remain Relatively Flat as Investors Wait for Fed Rate-Hike Move	MT
2022	Lixte Biotechnology Holdings, Inc. : Regulation FD Disclosure, Financial Statements and Ex..	AQ
2022	Lixte Biotechnology Holdings, Inc. : Regulation FD Disclosure, Financial Statements and Ex..	AQ
2022	Lixte Biotechnology Holdings, Inc. : Change in Directors or Principal Officers, Amendments..	AQ
2022	Lixte Biotechnology Holdings, Inc. Promotes Eric Forman to Vice President and Chief Ope..	CI

Chart LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Duration :

Period :

Lixte Biotechnology Holdings, Inc. Technical Analysis Chart | MarketScreener

Technical analysis trends LIXTE BIOTECHNOLOGY HOLDINGS, INC.

	Short Term	Mid-Term	Long Term
Trends	Bullish	Neutral	Bearish

Income Statement Evolution